Zoe Arvanitakis to Cognitive Dysfunction
This is a "connection" page, showing publications Zoe Arvanitakis has written about Cognitive Dysfunction.
Connection Strength
1.831
-
Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
Score: 0.450
-
Insulin resistance, cognition, and Alzheimer disease. Obesity (Silver Spring). 2023 06; 31(6):1486-1498.
Score: 0.438
-
Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
Score: 0.331
-
Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci. 2018 01 16; 73(2):198-203.
Score: 0.302
-
A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
Score: 0.093
-
Changes in Body Mass Index Are Related to Faster Cognitive Decline Among African American Older Adults. J Am Geriatr Soc. 2020 11; 68(11):2662-2667.
Score: 0.091
-
Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology. 2016 Oct 18; 87(16):1681-1687.
Score: 0.069
-
Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
Score: 0.057